Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.
<h4>Background</h4>Clinical studies demonstrate that the N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, induces rapid antidepressant effects in patients with refractive major depressive disorder and bipolar depression. This rapid onset of action makes ketamine a highly attrac...
Enregistré dans:
Auteurs principaux: | Xian-Cang Ma, Yong-Hui Dang, Min Jia, Rui Ma, Fen Wang, Jin Wu, Cheng-Ge Gao, Kenji Hashimoto |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f6d992536b5f434f962039d9df81ab91 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains
par: Ambika Krishnankutty, et autres
Publié: (2017) -
Immunoregulation and antidepressant effect of ketamine
par: Zhang Nan, et autres
Publié: (2021) -
Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus
par: Sandra G. Gonzalez Malagon, et autres
Publié: (2018) -
The role of dissociation in ketamine’s antidepressant effects
par: Elizabeth D. Ballard, et autres
Publié: (2020) -
Regulation of persistent sodium currents by glycogen synthase kinase 3 encodes daily rhythms of neuronal excitability
par: Jodi R. Paul, et autres
Publié: (2016)